Literature DB >> 9280237

Fetal central nervous system anomalies: MR imaging augments sonographic diagnosis.

D Levine1, P D Barnes, J R Madsen, W Li, R R Edelman.   

Abstract

PURPOSE: To evaluate fetuses with sonographically suspected central nervous system anomalies to determine the frequency with which obstetric magnetic resonance (MR) imaging adds clinically useful information to that provided by ultrasonography (US).
MATERIALS AND METHODS: US and MR images and diagnoses in 18 pregnant women were reviewed and compared by two radiologists. Postnatal physical examination and imaging findings and fetal autopsy results were standards. Referring physicians were questioned as to how the additional information provided by MR imaging changed patient counseling.
RESULTS: In 10 (55%) patients, MR imaging demonstrated 11 additional findings. These findings were agenesis of the corpus callosum (n = 4), cerebellar hypoplasia (n = 2), cortical cleft (n = 2), polymicrogyria (n = 1), porencephaly (n = 1), and partial agenesis of the septi pellucidi (n = 1). In seven (39%) patients, additional information provided by MR imaging altered counseling. In one case of suspected agenesis of the corpus callosum, diagnosis at MR imaging was at least partially incorrect.
CONCLUSION: US and MR imaging are complementary imaging methods in the evaluation of high-risk pregnancy. When a central nervous system anomaly is suspected at US, MR imaging may demonstrate additional findings that can alter patient counseling.

Entities:  

Mesh:

Year:  1997        PMID: 9280237     DOI: 10.1148/radiology.204.3.9280237

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  30 in total

1.  Screening of fetal CNS anomalies by MR imaging.

Authors:  Wan-Yuo Guo; Tai-Tong Wong
Journal:  Childs Nerv Syst       Date:  2003-06-18       Impact factor: 1.475

Review 2.  Recent developments in fetal medicine.

Authors:  Sailesh Kumar; Anna O'Brien
Journal:  BMJ       Date:  2004-04-24

3.  Early prenatal MR imaging diagnosis of polymicrogyria.

Authors:  Andrea Righini; Salvatore Zirpoli; Federica Mrakic; Cecilia Parazzini; Laura Pogliani; Fabio Triulzi
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

4.  The use of in utero MR imaging to delineate developmental brain abnormalities in multifetal pregnancies.

Authors:  P D Griffiths; S A Russell; G Mason; J Morris; E Fanou; M J Reeves
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-17       Impact factor: 3.825

5.  The use of in utero MRI to supplement ultrasound in the foetus at high risk of developmental brain or spine abnormality.

Authors:  P D Griffiths; M Porteous; G Mason; S Russell; J Morris; E M Fanou; M J Reeves
Journal:  Br J Radiol       Date:  2012-07-04       Impact factor: 3.039

6.  Fetuses with ventriculomegaly diagnosed in the second trimester of pregnancy by in utero MR imaging: what happens in the third trimester?

Authors:  P D Griffiths; J E Morris; G Mason; S A Russell; M N J Paley; E H Whitby; M J Reeves
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-09       Impact factor: 3.825

Review 7.  In utero magnetic resonance imaging for brain and spinal abnormalities in fetuses.

Authors:  Paul D Griffiths; Martyn N J Paley; Elysa Widjaja; Chris Taylor; Elspeth H Whitby
Journal:  BMJ       Date:  2005-09-10

Review 8.  Magnetic resonance imaging of the fetal brain and spine: an increasingly important tool in prenatal diagnosis, part 1.

Authors:  O A Glenn; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

Review 9.  Magnetic resonance imaging of the fetal brain and spine: an increasingly important tool in prenatal diagnosis: part 2.

Authors:  O A Glenn; J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

10.  MRI of the foetal brain using a rapid 3D steady-state sequence.

Authors:  P D Griffiths; D Jarvis; H McQuillan; F Williams; M Paley; P Armitage
Journal:  Br J Radiol       Date:  2013-10       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.